-+ 0.00%
-+ 0.00%
-+ 0.00%

Aditxt's Ignite Proteomics Was Featured In NPJ Precision Oncology

Benzinga·04/20/2026 12:16:47
Listen to the news

Peer-reviewed study finds standard HER2 IHC testing shows limited predictive value for T-DXd while Ignite's platform — the only commercially available multiplex assay in the study—demonstrates predictive value for patient outcomes